Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
Nature|January 7, 2021
Gut-licensed IFNγ<sup>+</sup> NK cells drive LAMP1<sup>+</sup>TRAIL<sup>+</sup> anti-inflammatory astrocytesLiliana M Sanmarco, Michael A Wheeler, Cristina Gutiérrez-Vázquez, et al.
Acta Neuropathologica|June 6, 2022
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrityDoryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Immunity|December 20, 2015
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate NeuroinflammationNatalia B Pikor, Jillian L Astarita, Leslie Summers-Deluca, et al.
Annals of Neurology|March 7, 2013
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantationPeter J Darlington, Tarik Touil, Jean-Sebastien Doucet, et al.
Journal of Neuroinflammation|May 30, 2023
Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencingMoein Yaqubi, Adam M R Groh, Marie-France Dorion, et al.
Acta Neuropathologica Communications|July 5, 2023
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosisMilton Guilherme Forestieri Fernandes, Abdulshakour Mohammadnia, Florian Pernin, et al.
Nature Immunology|November 17, 2016
Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
Multiple Sclerosis and Related Disorders|June 15, 2023
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated diseaseHayet Boudjani, Giulia Fadda, Gabrielle Dufort, et al.
Nature Immunology|October 11, 2016
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
Nature|January 7, 2021
Gut-licensed IFNγ<sup>+</sup> NK cells drive LAMP1<sup>+</sup>TRAIL<sup>+</sup> anti-inflammatory astrocytesLiliana M Sanmarco, Michael A Wheeler, Cristina Gutiérrez-Vázquez, et al.
Acta Neuropathologica|June 6, 2022
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrityDoryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Immunity|December 20, 2015
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate NeuroinflammationNatalia B Pikor, Jillian L Astarita, Leslie Summers-Deluca, et al.
Annals of Neurology|March 7, 2013
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantationPeter J Darlington, Tarik Touil, Jean-Sebastien Doucet, et al.
Journal of Neuroinflammation|May 30, 2023
Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencingMoein Yaqubi, Adam M R Groh, Marie-France Dorion, et al.
Acta Neuropathologica Communications|July 5, 2023
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosisMilton Guilherme Forestieri Fernandes, Abdulshakour Mohammadnia, Florian Pernin, et al.
Nature Immunology|November 17, 2016
Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
Multiple Sclerosis and Related Disorders|June 15, 2023
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated diseaseHayet Boudjani, Giulia Fadda, Gabrielle Dufort, et al.
Nature Immunology|October 11, 2016
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Pageof 27